Compare Stocks

→ Your Money is Not Safe (From American Alternative) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACP Abrdn Income Credit Strategies Fund	$6.39 -1.2%	$6.78	$5.55 ▼ $7.17	N/A	N/A	342,641 shs	112,547 shs
ASND Ascendis Pharma A/S	$138.15 -3.5%	$149.15	$66.03 ▼ $161.00	$8.04B	0.5	364,199 shs	47,248 shs
CLM Cornerstone Strategic Value Fund	$7.22 -1.0%	$7.39	$6.25 ▼ $8.84	N/A	1.13	1.44 million shs	399,758 shs

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACP Abrdn Income Credit Strategies Fund	-1.75%	-3.22%	-3.65%	-5.00%	-2.27%
ASND Ascendis Pharma A/S	-1.14%	+0.71%	-0.89%	+8.68%	+82.72%
CLM Cornerstone Strategic Value Fund	0.00%	0.00%	-2.45%	+0.98%	-6.63%

Your Money is Not Safe (Ad)

Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…

CLICK HERE TO GET YOUR GUIDE NOW

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ACP Abrdn Income Credit Strategies Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ASND Ascendis Pharma A/S	1.3661 of 5 stars	3.4	1.0	0.0	0.0	1.8	1.7	0.6
CLM Cornerstone Strategic Value Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ACP Abrdn Income Credit Strategies Fund	N/A	N/A	N/A	N/A
ASND Ascendis Pharma A/S	2.88	Moderate Buy	$173.25	25.41% Upside
CLM Cornerstone Strategic Value Fund	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest CLM, LKE, ASND, ACP, and GSN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/22/2024	ASND Ascendis Pharma A/S	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Equal Weight ➝ Equal Weight	$116.00 ➝ $116.00
4/18/2024	ASND Ascendis Pharma A/S	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$173.00
4/2/2024	ASND Ascendis Pharma A/S	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$165.00 ➝ $167.00
4/1/2024	ASND Ascendis Pharma A/S	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$173.00
3/15/2024	ASND Ascendis Pharma A/S	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$196.00 ➝ $260.00
2/8/2024	ASND Ascendis Pharma A/S	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$146.00 ➝ $182.00
2/8/2024	ASND Ascendis Pharma A/S	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$207.00 ➝ $225.00
2/6/2024	ASND Ascendis Pharma A/S	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$152.00 ➝ $173.00

(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ACP Abrdn Income Credit Strategies Fund	$31.54M	N/A	N/A	N/A	N/A	N/A
ASND Ascendis Pharma A/S	$288.08M	27.92	N/A	N/A	($2.73) per share	-50.60
CLM Cornerstone Strategic Value Fund	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ACP Abrdn Income Credit Strategies Fund	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
ASND Ascendis Pharma A/S	-$521.07M	-$9.25	N/A	N/A	N/A	-180.61%	-16,574.15%	-55.10%	4/25/2024 (Estimated)
CLM Cornerstone Strategic Value Fund	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Latest CLM, LKE, ASND, ACP, and GSN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
4/25/2024	N/A	ASND Ascendis Pharma A/S	N/A	-$1.60	-$1.60	N/A	N/A	N/A
2/7/2024	Q4 2023	ASND Ascendis Pharma A/S	-$2.15	-$1.66	+$0.49	-$1.66	$97.02 million	$148.62 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ACP Abrdn Income Credit Strategies Fund	$1.20	18.78%	+17.80%	N/A	N/A
ASND Ascendis Pharma A/S	N/A	N/A	N/A	N/A	N/A
CLM Cornerstone Strategic Value Fund	$1.42	19.67%	-12.82%	N/A	N/A

Latest CLM, LKE, ASND, ACP, and GSN Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/14/2024	CLM Cornerstone Strategic Value Fund	monthly	$0.1086	18.3%	6/14/2024	6/14/2024	6/28/2024
2/12/2024	CLM Cornerstone Strategic Value Fund	monthly	$0.1086	18.3%	5/14/2024	5/15/2024	5/31/2024
4/9/2024	ACP Abrdn Income Credit Strategies Fund	Monthly	$0.10	17.8%	4/22/2024	4/23/2024	4/30/2024
2/12/2024	CLM Cornerstone Strategic Value Fund	monthly	$0.1086	18.1%	4/12/2024	4/15/2024	4/30/2024
3/11/2024	ACP Abrdn Income Credit Strategies Fund	Monthly	$0.10	17.34%	3/20/2024	3/21/2024	3/28/2024
2/9/2024	ACP Abrdn Income Credit Strategies Fund	Monthly	$0.10	17.8%	2/21/2024	2/22/2024	2/29/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ACP Abrdn Income Credit Strategies Fund	N/A	N/A	N/A
ASND Ascendis Pharma A/S	N/A	3.56	2.50
CLM Cornerstone Strategic Value Fund	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
ACP Abrdn Income Credit Strategies Fund	N/A
ASND Ascendis Pharma A/S	N/A
CLM Cornerstone Strategic Value Fund	N/A

Insider Ownership

Company	Insider Ownership
ACP Abrdn Income Credit Strategies Fund	N/A
ASND Ascendis Pharma A/S	40.00%
CLM Cornerstone Strategic Value Fund	10.73%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ACP Abrdn Income Credit Strategies Fund	N/A	N/A	N/A	Not Optionable
ASND Ascendis Pharma A/S	879	58.22 million	34.93 million	Optionable
CLM Cornerstone Strategic Value Fund	N/A	N/A	N/A	Not Optionable

CLM, LKE, ASND, ACP, and GSN Headlines

Source	Headline
	Cornerstone Strategic Value Fund (NYSEAMERICAN:CLM) Stock Price Crosses Above 200-Day Moving Average of $0.00 americanbankingnews.com - April 24 at 3:26 AM
	Cornerstone Strategic Value Fund (NYSEAMERICAN:CLM) Stock Crosses Above 200-Day Moving Average of $0.00 americanbankingnews.com - April 16 at 2:54 AM
	Cornerstone Ventures Launches a Second Fund with USD 200 Mn Corpus for B2B Enterprises msn.com - April 10 at 9:51 AM
	Cornerstone Ventures launches second fund with $200 million target for investment in emerging B2B enterprise technology opportunities msn.com - April 10 at 8:26 AM
	Cornerstone Ventures Floats Second Fund With $200 Mn Corpus inc42.com - April 10 at 1:30 AM
	Closed End Funds That Offer A Discount To Reinvest seekingalpha.com - April 3 at 2:20 AM
	Citadel flagship fund rose 5.75% in Q1 -source msn.com - April 2 at 2:53 PM
	Cornerstone Strategic Value Fund money.usnews.com - March 23 at 5:46 PM
	Cornerstone Funds File Their Annual Reports globenewswire.com - March 1 at 9:00 AM
	AXA gains on new strategic plan to reward shareholders msn.com - February 22 at 7:03 AM
	CLM: Equity CEF With A 18% Yield seekingalpha.com - February 17 at 10:21 AM
	Cornerstone Strategic Value Fund, Inc. (CLM) finance.yahoo.com - February 10 at 10:01 AM
	GCM Grosvenor invests $50 million in woman-owned real estate fund pionline.com - February 6 at 7:35 AM
	Cornerstone Strategic Value Fund Inc. thestreet.com - February 2 at 4:41 PM
	Cornerstone Strategic Stock (AMEX:CLM) Dividends: History, Yield and Dates benzinga.com - January 17 at 1:02 PM
	Cornerstone Strategic Stock (AMEX:CLM), Analyst Ratings, Price Targets, Predictions benzinga.com - January 17 at 1:02 PM
	CLM: MDP Inconsistent With NAV Preservation, Avoid seekingalpha.com - December 7 at 8:23 AM
	SIT Investment Associates Inc Adds DWS Municipal Income Trust to Its Portfolio finance.yahoo.com - November 16 at 1:40 AM
	SIT Investment Associates Inc Acquires New Stake in Neuberger Berman High Yield Strategies Fund finance.yahoo.com - November 15 at 11:28 PM
	Cornerstone Strategic Value Fund cut dividend by -11.6% to $0.1086/share msn.com - November 3 at 8:02 PM
	CLM: The NAV Premium Shrinks Considerably msn.com - October 18 at 5:32 PM
	Cornerstone Strategic Value Fund Inc's Dividend Analysis finance.yahoo.com - October 12 at 10:02 AM
	SIT Investment Associates Inc Reduces Stake in First Trust Dynamic Europe Equity Income Fund finance.yahoo.com - August 9 at 3:24 PM
	XCLMX - Cornerstone Strategic Value Fund, Inc. finance.yahoo.com - June 9 at 7:55 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Abrdn Income Credit Strategies Fund

NYSE:ACP

Abrdn Income Credit Strategies Fund is a closed-ended fixed income fund launched and managed by Aberdeen Asset Managers Limited. It is co-managed by Aberdeen Standard Investments Inc. The fund invests in fixed income markets across the globe. It seeks to invest primarily in loan and debt instruments. Abrdn Income Credit Strategies Fund was formed on October 12, 2010 and is domiciled in the United States.

Ascendis Pharma A/S

NASDAQ:ASND

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Cornerstone Strategic Value Fund

NYSEAMERICAN:CLM

Cornerstone Strategic Value Fund, Inc. is a closed-ended equity mutual fund launched and managed by Cornerstone Advisors, LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in value and growth stocks of companies. It also invests through other closed-end investment companies and ETF's. Cornerstone Strategic Value Fund, Inc. was formed on May 1, 1987 and is domiciled in the United States.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial